Ozone Drives Macrophage Efferocytosis to Mitigate Neuropathic Pain

Study Background and Research Question

Neuropathic pain (NPP) is a complex, often intractable syndrome resulting from nerve injury or underlying disease, affecting approximately 7%-10% of the population according to recent evidence. Standard treatments, including antidepressants and anticonvulsants, frequently yield insufficient relief and cause adverse effects, underscoring the need for new therapeutic strategies. Accumulation of apoptotic cells and sustained neuroinflammation are recognized as principal contributors to the pathogenesis of NPP. However, interventions directly targeting apoptotic cell clearance to reduce neuroinflammation and pain remain underexplored. The reference study addresses this gap by testing whether ozone therapy can enhance macrophage-mediated efferocytosis—the process by which apoptotic cells are cleared—and thereby alleviate neuropathic pain.

Key Innovation from the Reference Study

The principal innovation of the study by Ruan et al. (2024) is the demonstration that ozone treatment modulates macrophage function through the AMPK/Gas6-MerTK/SOCS3 signaling axis. By leveraging ozone's capacity to activate AMP-activated protein kinase (AMPK), the study shows subsequent upregulation of growth arrest-specific 6 (Gas6), activation of the MerTK receptor, and increased expression of suppressor of cytokine signaling 3 (SOCS3). This coordinated signaling cascade significantly enhances the efferocytosis of apoptotic neutrophils by bone marrow-derived macrophages (BMDM), leading to a reduction in neuroinflammatory mediators and pain behaviors in a mouse model of chronic constriction injury (CCI). Crucially, the study not only identifies this pathway but also experimentally validates its necessity by employing specific pathway inhibitors.

Methods and Experimental Design Insights

The research used both in vivo and in vitro approaches to dissect ozone's effects on neuropathic pain and macrophage function:

• CCI mouse models were established to mimic neuropathic pain, with ozone administered at graded concentrations (15 mg, 30 mg, 45 mg).
• Behavioral assays measured mechanical hypersensitivity to assess pain relief following ozone treatment.
• BMDMs were isolated and their phagocytic activity toward apoptotic neutrophils was quantified after ozone exposure.
• Pathway involvement was probed by co-administering the AMPK inhibitor Compound C and the MerTK inhibitor UNC2541.
• mRNA and protein expression levels of Gas6, MerTK, SOCS3, and inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured to confirm molecular pathway activation.

This multifaceted design enabled the authors to link behavioral outcomes with cellular and molecular mechanisms, providing robust evidence for the role of the AMPK/Gas6-MerTK/SOCS3 axis in ozone-driven efferocytosis and neuropathic pain mitigation (full details).

Protocol Parameters

• Ozone administration: 30 mg concentration was most effective in alleviating pain and promoting efferocytosis in CCI mice.
• Pathway inhibition: Co-treatment with Compound C (AMPK inhibitor) or UNC2541 (MerTK inhibitor) abolished the beneficial effects of ozone, confirming pathway specificity.
• Cellular assays: BMDMs were exposed to ozone-treated environments prior to phagocytosis assays with apoptotic neutrophils.

Core Findings and Why They Matter

The study’s central findings are twofold:

1. Ozone at 30 mg significantly reduced mechanical hypersensitivity in CCI-induced neuropathic pain mice, providing behavioral evidence for analgesia.
2. Ozone treatment enhanced BMDM-mediated clearance of apoptotic neutrophils via the AMPK/Gas6-MerTK/SOCS3 pathway. This led to downregulation of key pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), indicating effective resolution of neuroinflammation.

Mechanistically, ozone’s activation of AMPK drove Gas6 upregulation, selectively engaging the MerTK receptor (not Protein S or other TAM family members), and inducing SOCS3 expression. The inhibition experiments were critical, as blocking either AMPK or MerTK abrogated ozone’s effects, firmly establishing causality. These findings advance our understanding of efferocytosis as a therapeutic target in pain states. They also provide a mechanistic rationale for ozone therapy, which has previously been considered empirical, and identify actionable nodes for future pharmacological intervention in chronic pain and neuroinflammation.

Comparison with Existing Internal Articles

Several recent reviews and research articles have addressed the analytical tools and biological frameworks relevant to the study:

• The article "Ozone Enhances Macrophage Efferocytosis to Relieve Neuropathic Pain" offers a summary of ozone’s immunomodulatory effects, emphasizing the importance of macrophage-mediated apoptotic cell clearance in pain resolution, in line with the reference study.
• On the methodological front, research into extracellular pH dynamics—such as "BCECF: Precision pH Sensing for Microenvironmental Research"—highlights the critical role of acid-base homeostasis in inflammation and cellular metabolism. While the reference study did not directly employ BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) as a fluorescent pH probe for ion transport studies, its experimental paradigm could benefit from high-resolution, ratiometric tools for monitoring extracellular pH shifts associated with macrophage activation and efferocytosis.
• Complementary articles such as "BCECF for Precision Extracellular pH Mapping in Microenvironmental Studies" discuss how pH-sensitive dyes enable nuanced tracking of microenvironmental changes during immune cell function, offering potential methodological extensions for future studies of neuroinflammation.

Limitations and Transferability

The study’s strengths include its mechanistic depth, use of pathway-specific inhibitors, and robust behavioral readouts. However, several limitations warrant consideration:

• The findings are based on a murine CCI model, which, while widely used, may not fully recapitulate the complexities of human neuropathic pain.
• The direct link between ozone therapy and clinical benefit remains to be established in human trials, particularly with respect to safety and dosage optimization.
• While the pathway focus was on AMPK/Gas6-MerTK/SOCS3, other parallel or downstream effectors were not exhaustively characterized.
• Potential effects of ozone on other immune populations and broader tissue microenvironments were not explored.

Nevertheless, the mechanistic clarity and experimental rigor provide a strong foundation for translational exploration.

Research Support Resources

For researchers aiming to investigate microenvironmental pH regulation assay workflows or to dissect acid-base homeostasis during immune cell activity, BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) (SKU C5694) from APExBIO is a well-characterized, cell-impermeant ratiometric pH indicator. Its use facilitates precise quantification of extracellular pH dynamics, which are relevant in assays examining macrophage function, efferocytosis, or inflammatory responses. For further technical background and workflow guidance, see related reviews on fluorescent pH probes for cellular metabolism pH monitoring.